New urine-based test shows promise in making cervical cancer screening more accessible and less invasive

Detection of HPV16 E7 oncoproteins in urine samples using ultrasensitive enzyme-linked immunosorbent assay Image caption: Researchers have now validated a noninvasive method for screening cervical cancer. This could open new avenues for cancer screening by collection of urine sample by the patients themselves and then delivering it to medical facility for testing. This alternative method is a step forward to eradicate cervical cancer by lowering the barriers related to screening. Credit: Dr. Etsuro Ito from Waseda University Cervical cancer is one of the most common cancers in women, with approximately Read More

Related posts:

  1. New urine test can improve accuracy for early detection of bladder cancer in patients with hematuria
  2. New surgical method shows promising results for cervical cancer treatment
  3. Community-based screening analysis emphasizes need for hypertension screening in young athletes
  4. New combination therapy shows promise for bladder cancer patients unresponsive to standard treatment
  5. Stem cell-derived therapy shows promise against treatment-resistant liver cancer
  6. How the human hippocampus contributes to value-based decision-making under uncertainty
  7. What is cervical cancer and how can it be prevented? Answers to key questions
  8. Tisotumab vedotin found efficacious for recurrent cervical cancer

Leave a Reply

Your email address will not be published. Required fields are marked *